A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Other news to note for March 6, 2026
Other news to note for March 6, 2026
Regulatory actions for March 6, 2026
Regulatory actions for March 6, 2026
Cas and effect: Merck’s phase III ripples HIF-2α space
Cas and effect: Merck’s phase III ripples HIF-2α space
Money raised by biopharma
Money raised by biopharma
Biopharma money raised: Jan. 1-March 5, 2026
Biopharma money raised: Jan. 1-March 5, 2026
BioWorld and Nasdaq stock indices
BioWorld and Nasdaq stock indices
Biopharma money raised by month in 2026 (US$M)
Biopharma money raised by month in 2026 (US$M)
Appointments and advancements for March 5, 2026
Appointments and advancements for March 5, 2026
Financings for March 5, 2026
Financings for March 5, 2026
In the clinic for March 5, 2026
In the clinic for March 5, 2026
Other news to note for March 5, 2026
Other news to note for March 5, 2026
Regulatory actions for March 5, 2026
Regulatory actions for March 5, 2026
Brain’s hidden tau-clearing pathway uncovered
Brain’s hidden tau-clearing pathway uncovered
Shares drop as Pepgen reports partial hold on DM1 phase II
Shares drop as Pepgen reports partial hold on DM1 phase II
Haisco Pharmaceutical discloses FGFR2 and FGFR3 inhibitors
Haisco Pharmaceutical discloses FGFR2 and FGFR3 inhibitors
Hangzhou Innogate and Innorace divulge MRGPRX2 antagonists
Hangzhou Innogate and Innorace divulge MRGPRX2 antagonists
Alternative splicing strategy shows promise for Rett syndrome
Alternative splicing strategy shows promise for Rett syndrome
Financings for March 4, 2026
Financings for March 4, 2026
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page